In some recent studies, normalization of alanine aminotransferase (ALT) during NA therapy was reported as being associated with a low risk of HCC [20,21,22], but the cut-off of ALT normalization and the timing of judgment has not been sufficiently evaluated. This evidence concerns the gene GPT and hepatocellular carcinoma.